Physician profile
Pial Mahmud Hope
NPI 1760903868
$17,382.61
in general payments reported to CMS, 2019-2025
17 companies · $2,055 in 2025
The $2,055 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $40.15 · 2021: $221 · 2022: $4,419 · 2023: $3,356 · 2024: $6,948 · 2025: $2,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,130 · Travel and Lodging: $3,725 · Food and Beverage: $2,488 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,130.28 |
| Travel and Lodging | $3,724.65 |
| Food and Beverage | $2,488.49 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,766.32 | 2019-2025 | Davinci Xi |
| Medtronic, INC. | $2,517.83 | 2022-2025 | Progrip, Signia, Endoflip |
| Davol INC. | $1,393.31 | 2019-2025 | Phasix Mesh |
| Medical Device Business Services, INC. | $610.00 | 2022 | |
| Tela Bio, INC. | $235.69 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $234.20 | 2022-2023 | Seamguard Staple Line Reinforcement |
| Integra Lifesciences Corporation | $148.37 | 2021-2022 | |
| Ethicon US, LLC | $140.51 | 2022-2023 | Echelon Flex, Vistaseal, Echelon Endopath |
| Depuy Synthes Sales INC. | $91.55 | 2019 | |
| Csl Behring | $70.27 | 2019-2020 | |
| Baudax Bio INC. | $51.07 | 2022 | |
| Boston Scientific Corporation | $36.75 | 2025 | Spyglass Discover |
| Fisher & Paykel Healthcare INC | $25.62 | 2023 | Fisher & Paykel Healthcare |
| Cardiovascular Systems INC. | $22.50 | 2021 | |
| Endo Pharmaceuticals INC. | $17.41 | 2023 | Nascobal |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eagle Pharmaceuticals, INC. | $15.19 | 2022 | |
| Reshape Lifesciences INC. | $6.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pial Hope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.